Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET
Company Participants
David DeMartino – Senior Vice President-Investor Relations
Ivan Tornos – President and Chief Executive Officer
Suketu Upadhyay – Chief Financial Officer and Executive Vice President-Finance, Operations and Supply Chain
Conference Call Participants
Travis Steed – Bank of America
Vik Chopra – Wells Fargo
David Roman – Goldman Sachs
Allen Gong – JPMorgan
Matthew O’Brien – Piper Sandler
Chris Pasquale – Nephron
Steve Lichtman – Oppenheimer
Sophia Knopp – Evercore ISI
Richard Newitter – Truist Securities
Jeff Johnson – Baird
Caitlin Cronin – Canaccord
Mike Matson – Needham & Company
Shagun Singh – RBC Capital Markets
Operator
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, October 30, 2024. Following today’s presentation there will be a question-and-answer session. At this time all participants are in a listen-only mode. [Operator Instructions]
I would now like to turn the conference over to David DeMartino, Senior Vice President of Investor Relations. Please go ahead.
David DeMartino
Thank you, operator, and good morning, everyone. Welcome to Zimmer Biomet’s third quarter 2021 earnings conference call. Joining me on today’s call are Ivan Tornos, our President and CEO; and CFO and EVP, Finance, Operations and Supply Chain, Suketu Upadhyay.
Before we get started, I’d like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please note, we assume no obligation to update these forward-looking statements even if actual results or future expectations change materially.
Please refer to our SEC filings for a detailed discussion of these
Read the full article here